Economic impact of drug-related morbidity in Sweden –

(1)

Economic impact of drug-related morbidity in Sweden

– Estimated using experts’ opinion, medical records and self-reports.

Hanna Gyllensten

Errata

Svensk sammanfattning

Andra stycket: ... Förutom direkta kostnader för läkemedelsrelaterad sjuklighet... Tredje stycket: ...7000-15000 kronor...

Tredje stycket: ... Om man utgår från de totala årliga kostnaderna i Sverige så motsvarar skattningarna från journal- och enkätdata...

List of papers (i) and ”spikblad”

Paper II, authors: Hakkarainen, KM, Alström, D, Hägg, S, Carlsten, A, Gyllensten, H.

Introduction

Heading 1.2, 3rd paragraph: ...“harm resulting from the (appropriate or inappropriate) use of a drug” and “an injury resulting from medical intervention related to a drug”.[1]

Heading 1.2, 4th_{paragraph: ...the error rates were more than...}

Heading 1.3, 4th paragraph: ...opiates and narcotics, and anticoagulants.[49] Heading 1.5, 3rd paragraph: ...data.[51] It appears that the...

Results

Heading 4.1.6, 2nd paragraph: ... Moreover, of the 234 patients with encounters...

Heading 4.3, 4th paragraph: ...to the Swedish population, the figures from the study of medical records and from the survey were applied...

Heading 4.3, 5th paragraph: In table 5 are presented the monthly costs resulting from drug-related morbidity extrapolated to 100000 residents, estimated from the results in papers III-IV. For example, based on the results...

Discussion

Heading 6.1.1/Using healthcare professionals’ opinion (papers I-II), 1st paragraph: ...was apparent in the literature review,[54] e.g. on the costs occurring outside hospitals...